CD20-directed Antibody Interactions [MoA] - N0000175078

Pharmacologic Class Information

Pharmacologic Code N0000175078
Pharmacologic Name CD20-directed Antibody Interactions
Pharmacologic Uses
  • CD20-directed cytolytic antibody
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with CD20-directed Antibody Interactions

The following table contains 15 products whose active ingredient are classified under the same pharmacologic class CD20-directed Antibody Interactions [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0238Ruxience Non-Proprietary Name: Rituximab-pvvrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
0069-0249Ruxience Non-Proprietary Name: Rituximab-pvvrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
0078-0669Arzerra Non-Proprietary Name: OfatumumabInjection, SolutionIntravenousNovartis Pharmaceuticals CorporationACTIVE
0078-0690Arzerra Non-Proprietary Name: OfatumumabInjection, SolutionIntravenousNovartis Pharmaceuticals CorporationACTIVE
0078-1007Kesimpta Non-Proprietary Name: OfatumumabInjection, SolutionSubcutaneousNovartis Pharmaceuticals CorporationACTIVE
50242-051Rituxan Non-Proprietary Name: RituximabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-053Rituxan Non-Proprietary Name: RituximabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-070Gazyva Non-Proprietary Name: ObinutuzumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-108Rituxan Hycela Non-Proprietary Name: Rituximab And HyaluronidaseInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-109Rituxan Hycela Non-Proprietary Name: Rituximab And HyaluronidaseInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-150Ocrevus Non-Proprietary Name: OcrelizumabInjectionIntravenousGenentech, Inc.ACTIVE
55513-224Riabni Non-Proprietary Name: Rituximab-arrxInjection, SolutionIntravenousAmgen IncACTIVE
55513-326Riabni Non-Proprietary Name: Rituximab-arrxInjection, SolutionIntravenousAmgen IncACTIVE
63459-103Truxima Non-Proprietary Name: Rituximab-abbsInjection, SolutionIntravenousCephalon, Inc.ACTIVE
63459-104Truxima Non-Proprietary Name: Rituximab-abbsInjection, SolutionIntravenousCephalon, Inc.ACTIVE